High-dose third-generation EGFR-TKIs combined with intrathecal pemetrexed in advanced EGFR-mutant NSCLC with leptomeningeal metastases following EGFR-TKI therapy
Shugui Wu, Zhengang Qiu, Huaqiu Shi, Wei Yu, Linfang Liu, Longqiu Wu et al. High-dose third-generation EGFR-TKIs combined with intrathecal pemetrexed in advanced EGFR-mutant NSCLC with leptomeningeal metastases following EGFR-TKI therapy. // BMC Cancer. – 2025. – DOI: 10.1186/s12885-025-14337-z. – URL: https://doi.org/10.1186/s12885-025-14337-z
Shugui Wu, Zhengang Qiu, Huaqiu Shi, Wei Yu, Linfang Liu, Longqiu Wu, & Wenjuan Zhong (2025). High-dose third-generation EGFR-TKIs combined with intrathecal pemetrexed in advanced EGFR-mutant NSCLC with leptomeningeal metastases following EGFR-TKI therapy. BMC Cancer. https://doi.org/10.1186/s12885-025-14337-z
Shugui Wu, et al. “High-dose third-generation EGFR-TKIs combined with intrathecal pemetrexed in advanced EGFR-mutant NSCLC with leptomeningeal metastases following EGFR-TKI therapy.” BMC Cancer, 2025. doi:10.1186/s12885-025-14337-z.
@article{Wu2025,
title = {High-dose third-generation EGFR-TKIs combined with intrathecal pemetrexed in advanced EGFR-mutant NSCLC with leptomeningeal metastases following EGFR-TKI therapy},
author = {Wu, Shugui and Qiu, Zhengang and Shi, Huaqiu and Yu, Wei and Liu, Linfang and Wu, Longqiu and Zhong, Wenjuan},
journal = {BMC Cancer},
year = {2025},
doi = {10.1186/s12885-025-14337-z},
url = {https://doi.org/10.1186/s12885-025-14337-z}
}